Atlas Trials

Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face

Clinical trial NCT02723721 · COMPLETED

Trial details

NCT number
NCT02723721
Sponsor
Centre Hospitalier Universitaire de Nice
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lentigo Maligna
Start date
2016-06-15
Primary completion
2020-01-27
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.